Menu
Go
About
Team
Research
Modeling
Clinical
Projects
News
Publications
Careers
Translational
Science
Entrepreneurship
Modeling and AI
Applying AI to unravel the complexity of the immune system as a massively and dynamically interacting system.
In The News
The NIMML Institute and NImmune Biopharma Showcase How the TITAN-X A.I. Platform has Accelerated Therapeutic Development in the Annual Review of Biomedical Data Science
Apr 21, 2025
NIMML Institute to Present Novel Clinical and Translational Data of Omilancor in Ulcerative Colitis Patients at Digestive Disease Week 2025
Apr 10, 2025
The NIMML Institute and NImmune Biopharma Announce Publication of New Mechanistic Insights on the Immunometabolic Control of Systemic Lupus Erythematosus in the Journal of Immunology
Oct 07, 2024
Translational and Clinical Science
View All
The NIMML Institute and NImmune Biopharma Announce Publication of Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus, in Clinical and Translational Science
Jan 13, 2025
NIMML Presents Positive First-in-Human Data of NIM-1324, a Phase 2 Candidate for Systemic Lupus Erythematosus at the American College of Rheumatology Convergence 2023 (#ACR23)
Nov 14, 2023
NIMML Announces Positive Results of Omilancor Clinical Trials in Ulcerative Colitis and Crohn’s Disease at the American College of Gastroenterology 2023 Annual Scientific Meeting
Oct 23, 2023
Entrepreneurship
View All
NIMML Institute and NImmune Biopharma Partner to Advance Precision Medicine Research for Autoimmune Diseases
May 03, 2023
The NIMML Institute Founder Launches NImmune Biopharma to Develop Late-Stage Breakthrough Immunoregulatory Medicines for Autoimmune Diseases
Mar 22, 2023
Landos Biopharma to Present at the 38th Annual J.P. Morgan Healthcare Conference
Jan 09, 2020
Modeling and AI
View All
NIMML Announces Publication of New Mechanistic Insights on the Metabolic Control of Inflammation and Infection in Scientific Reports
Sep 12, 2023
NIMML Launches A.I. Powered TITAN-X Platform to Accelerate Development of Precision Immunology Therapeutics
Jun 20, 2023
The NIMML Institute Launches New Tool for Rapidly Analyzing Host Metabolic Profiles from Global Transcriptomics Datasets
May 22, 2023
